# A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF

Study · id `cardio:ct-nct07173673` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07173673](<https://clinicaltrials.gov/study/NCT07173673>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07173673

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1230 participants.

## Technical summary

Registry record NCT07173673. Randomized; no masking; primary purpose diagnostic. Start 2025-11 (anticipated); primary completion 2027-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 1230 participants (planned count; ClinicalTrials.gov record NCT07173673, source copy `cardio:ctgov-nct07173673-2025-09-15`, retrieved 2026-10-31)
- Planned start: 2025-11 (anticipated) (ClinicalTrials.gov record NCT07173673, source copy `cardio:ctgov-nct07173673-2025-09-15`, retrieved 2026-10-31)
- Primary completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT07173673, source copy `cardio:ctgov-nct07173673-2025-09-15`, retrieved 2026-10-31)
- Completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT07173673, source copy `cardio:ctgov-nct07173673-2025-09-15`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT07173673, source copy `cardio:ctgov-nct07173673-2025-09-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07173673-2025-09-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF
- Condition: Atrial Fibrillation
- Intervention (Other): Usual Care (General Practice)
- Intervention (Device): AI-ECG Guided Care (SmartECG-AFrisk)
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: fbb2286dd8f66f02a338ffba65478db659f51625241e49015665d04fe7464f64
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
